Due to the emergence of various highly contagious variants of SARS-CoV-2, vaccine boosters were adopted as a complementary strategy in different countries. This strategy has, however, posed another challenge for the national authorities to convince their population to receive the booster after the first challenge of COVID-19 primer dose vaccines. This study was conducted to determine COVID-19 vaccine booster acceptance and its associated factors in the general population in Algeria. Using social media platforms, an online self-administered questionnaire was distributed between 28 January and 5 March 2022 for all Algerian citizens who received COVID-19 vaccines. Overall, 787 respondents were included in this study. Among them, 51.6%, 25%, and 23.8% accepted, rejected, or were hesitant about the COVID-19 vaccine booster, respectively. However, only 13.2% declared receiving the booster dose. Additionally, while 58.2% of the respondents declared being relieved after primer vaccination, 11.4% among them declared that they regretted being vaccinated. The most common reasons for acceptance were experts' recommendations (24.6%) and the belief that COVID-19 vaccine boosters were necessary and efficient, while rejection was mainly due to the belief that primer doses are sufficient (15.5%), or that vaccination in general is inefficient (8%). Males, older individuals, those with chronic comorbidities or a history of COVID-19 infection, non-healthcare workers, and those with low educational levels were associated with significantly higher odds for booster acceptance. Moreover, belief that booster doses were necessary and efficient, disagreeing with the notion that primer doses were not sufficient, experts' recommendations, and the desire to travel abroad were significantly associated with higher odds of COVID-19 vaccine booster acceptance.

Department of Agro Veterinary Science Faculty of Natural and Life Sciences University of Ziane Achour Djelfa 17000 Algeria

Department of Biology Faculty of Natural and Life Sciences University of Ziane Achour Djelfa 17000 Algeria

Department of Dentistry Faculty of Medicine University of Algiers Benyoucef Benkhedda Algiers 16000 Algeria

Department of Public Health Faculty of Medicine Masaryk University 625 00 Brno Czech Republic

Zobrazit více v PubMed

World Health Organization (WHO) Coronavirus (COVID-19) Dashboard. [(accessed on 23 March 2022)]. Available online: https://covid19.who.int/

Lazarus J.V., Ratzan S., Palayew A., Billari F.C., Binagwaho A., Kimball S., Larson H.J., Melegaro A., Rabin K., White T.M., et al. COVID-SCORE: A global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10) PLoS ONE. 2020;15:e0240011. doi: 10.1371/journal.pone.0240011. PubMed DOI PMC

Alqudeimat Y., Alenezi D., AlHajri B., Alfouzan H., Almokhaizeem Z., Altamimi S., Almansouri W., Alzalzalah S., Ziyab A.H. Acceptance of a COVID-19 Vaccine and Its Related Determinants among the General Adult Population in Kuwait. Med. Princ. Pr. 2021;30:262–271. doi: 10.1159/000514636. PubMed DOI PMC

Burki T.K. Herd immunity for COVID-19. Lancet Respir. Med. 2021;9:135–136. doi: 10.1016/S2213-2600(20)30555-5. PubMed DOI PMC

Randolph H.E., Barreiro L.B. Herd Immunity: Understanding COVID-19. Immunity. 2020;52:737–741. doi: 10.1016/j.immuni.2020.04.012. PubMed DOI PMC

World Health Organization (WHO) Coronavirus Disease (COVID-19): Herd Immunity, Lockdowns and COVID-19. 2020. [(accessed on 26 March 2022)]. Available online: https://www.who.int/news-room/questions-and-answers/item/herd-immunity-lockdowns-and-covid-19.

Anderson R.M., Vegvari C., Truscott J., Collyer B.S. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. Lancet. 2020;396:1614–1616. doi: 10.1016/S0140-6736(20)32318-7. PubMed DOI PMC

World Health Organization COVID-19 Vaccine Tracker. [(accessed on 21 November 2021)]. Available online: https://covid19.trackvaccines.org/agency/who/

Ourworlindata. 2022. [(accessed on 23 March 2022)]. Available online: https://ourworldindata.org/covid-vaccinations.

Riad A., Pokorná A., Antalová N., Krobot M., Zviadadze N., Serdiuk I., Koščík M., Klugar M. Prevalence and drivers of COVID-19 vaccine hesitancy among Czech university students: National cross-sectional study. Vaccines. 2021;9:948. doi: 10.3390/vaccines9090948. PubMed DOI PMC

Riad A., Jouzová A., Üstün B., Lagová E., Hruban L., Janků P., Pokorná A., Klugarová J., Koščík M., Klugar M. COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study. Int. J. Environ. Res. Public Health. 2021;18:13373. doi: 10.3390/ijerph182413373. PubMed DOI PMC

Kateeb E., Danadneh M., Pokorná A., Klugarová J., Abdulqader H., Klugar M., Riad A. Predictors of Willingness to Receive COVID-19 Vaccine: Cross-Sectional Study of Palestinian Dental Students. Vaccines. 2021;9:954. doi: 10.3390/vaccines9090954. PubMed DOI PMC

Nguyen L.H., Joshi A.D., Drew D.A., Merino J., Ma W., Lo C.-H., Kwon S., Wang K., Graham M.S., Polidori L., et al. Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom. Nat. Commun. 2022;13:636. doi: 10.1038/s41467-022-28200-3. PubMed DOI PMC

Wagner A.L., Huang Z., Ren J., Laffoon M., Ji M., Pinckney L.C., Sun X., Prosser L.A., Boulton M.L., Zikmund-Fisher B.J. Vaccine hesitancy and concerns about vaccine safety and effectiveness in Shanghai, China. Am. J. Prev. Med. 2021;60:S77–S86. doi: 10.1016/j.amepre.2020.09.003. PubMed DOI PMC

Hulen E., Rynerson A.L., Dobscha S.K. Vaccine hesitancy among Veterans Affairs Health Care System employees. Prev. Med. Rep. 2022;26:101702. doi: 10.1016/j.pmedr.2022.101702. PubMed DOI PMC

Strupat C., Shigute Z., Bedi A.S., Rieger M. Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia. PLoS ONE. 2022;17:e0264633. doi: 10.1371/journal.pone.0264633. PubMed DOI PMC

Dolgin E. Omicron is supercharging the COVID vaccine booster debate. Nature. 2021;10 doi: 10.1038/d41586-021-03592-2. PubMed DOI

Pal S., Shekhar R., Kottewar S., Upadhyay S., Singh M., Pathak D., Kapuria D., Barrett E., Sheikh A.B. COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers. Vaccines. 2021;9:1358. doi: 10.3390/vaccines9111358. PubMed DOI PMC

Yadete T., Batra K., Netski D.M., Antonio S., Patros M.J., Bester J.C. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: A cross-sectional study. Vaccines. 2021;9:1424. doi: 10.3390/vaccines9121424. PubMed DOI PMC

Rzymski P., Poniedziałek B., Fal A. Willingness to receive the booster COVID-19 vaccine dose in Poland. Vaccines. 2021;9:1286. doi: 10.3390/vaccines9111286. PubMed DOI PMC

Klugar M., Riad A., Mohanan L., Pokorná A. COVID-19 vaccine booster hesitancy (VBH) of healthcare workers in Czechia: National cross-sectional study. Vaccines. 2021;9:1437. doi: 10.3390/vaccines9121437. PubMed DOI PMC

Attia S., Mausbach K., Klugar M., Howaldt H.-P., Riad A. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees. Front. Public Health. 2022;10:706. doi: 10.3389/fpubh.2022.846861. PubMed DOI PMC

Sugawara N., Yasui-Furukori N., Fukushima A., Shimoda K. Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine? Vaccines. 2021;9:1295. doi: 10.3390/vaccines9111295. PubMed DOI PMC

Tung T.-H., Lin X.-Q., Chen Y., Zhang M.-X., Zhu J.-S. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China. Expert Rev. Vaccines. 2021;21:261–267. doi: 10.1080/14760584.2022.2016401. PubMed DOI

Qin C., Wang R., Tao L., Liu M., Liu J. Acceptance of a Third Dose of COVID-19 Vaccine and Associated Factors in China Based on Health Belief Model: A National Cross-Sectional Study. Vaccines. 2022;10:89. doi: 10.3390/vaccines10010089. PubMed DOI PMC

Jørgensen F.J., Nielsen L.H., Petersen M.B. Willingness to Take the Booster Vaccine in a Nationally Representative Sample of Danes. Vaccines. 2022;10:425. doi: 10.3390/vaccines10030425. PubMed DOI PMC

Kacimi S.E.O., Klouche-Djedid S.N., Riffi O., Belaouni H.A., Yasmine F., Taouza F.A., Belakhdar Y., Fellah S.C., Benmelouka A.Y., Ahmed S., et al. Determinants of SARS-CoV-2 Vaccine Engagement in Algeria: A Population-based Study with Systematic Review of Studies from Arab Countries of the MENA Region. medRxiv. 2021 doi: 10.1101/2021.07.17.21260662. PubMed DOI PMC

Kaadan M.I., Abdulkarim J., Chaar M., Zayegh O., Keblawi M.A. Determinants of COVID-19 vaccine acceptance in the Arab world: A cross-sectional study. Glob. Health Res. Policy. 2021;6:23. doi: 10.1186/s41256-021-00202-6. PubMed DOI PMC

Qunaibi E., Basheti I., Soudy M., Sultan I. Hesitancy of Arab Healthcare Workers towards COVID-19 Vaccination: A Large-Scale Multinational Study. Vaccines. 2021;9:446. doi: 10.3390/vaccines9050446. PubMed DOI PMC

Kerdoun M.A., Henni A.H., Yamoun A., Rahmani A., Kerdoun R.M., Elouar N. COVID-19 vaccine hesitancy among Algerian medical students: A cross-sectional study in five universities. medRxiv. 2021 doi: 10.1101/2021.08.29.21261803. DOI

Lounis M., Abdehadi S., Rais M.A., Bencherit D., Sallam M. Intention to get COVID-19 vaccination and its associated predictors: A cross-sectional study among the general public in Algeria. Vacunas. 2022 (accepted) PubMed PMC

Ourworlindata Coronavirus (COVID-19) Vaccinations. 2022. [(accessed on 23 March 2022)]. Available online: https://ourworldindata.org/grapher/cumulative-covid-vaccine-booster-doses?country=~DZA.

von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. BMJ. 2007;335:806–808. doi: 10.1136/bmj.39335.541782.AD. PubMed DOI PMC

Centers for Disease Control and Prevention (CDC) Epi InfoTM for Windows. [(accessed on 25 December 2020)];2020 Available online: https://www.cdc.gov/epiinfo/pc.html.

World Medical Association World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA J. Am. Med. Assoc. 2013;310:2191–2194. doi: 10.1001/jama.2013.281053. PubMed DOI

Proton Technologies AG. General Data Protection Regulation (GDPR) Compliance Guidelines HORIZON 2020-Project REP-791727-1. 2020. [(accessed on 1 May 2020)]. Available online: https://gdpr.eu/

SPSS Inc IBM SPSS Statistics 28. 2021. [(accessed on 14 March 2021)]. Available online: https://www.ibm.com/support/pages/ibm-spss-statistics-28-documentation.

The Jamovi Project Jamovi (Version 1.6) [Computer Software] 2021. [(accessed on 11 February 2022)]. Available online: https://www.jamovi.org.

Alhasan K., Aljamaan F., Temsah M.-H., Alshahrani F., Bassrawi R., Alhaboob A., Assiri R., Alenezi S., Alaraj A., Alhomoudi R.I., et al. COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers. Healthcare. 2021;9:1566. doi: 10.3390/healthcare9111566. PubMed DOI PMC

Al-Qerem W., Al Bawab A.Q., Hammad A., Ling J., Alasmari F. Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study. Vaccines. 2022;10:410. doi: 10.3390/vaccines10030410. PubMed DOI PMC

Babicki M., Mastalerz-Migas A. Attitudes of Poles towards the COVID-19 Vaccine Booster Dose: An Online Survey in Poland. Vaccines. 2022;10:68. doi: 10.3390/vaccines10010068. PubMed DOI PMC

Folcarelli L., del Giudice G.M., Corea F., Angelillo I.F. Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy. Vaccines. 2022;10:146. doi: 10.3390/vaccines10020146. PubMed DOI PMC

Lai X., Zhu H., Wang J., Huang Y., Jing R., Lyu Y., Zhang H., Feng H., Guo J., Fang H. Public Perceptions and Acceptance of COVID-19 Booster Vaccination in China: A Cross-Sectional Study. Vaccines. 2021;9:1461. doi: 10.3390/vaccines9121461. PubMed DOI PMC

World Health Organization Strategic Advisory Group of Experts on Immunization SAGE. [(accessed on 23 March 2022)]. Available online: https://www.who.int/news/item/04-10-2021-interim-statement-on-booster-doses-for-covid-19-vaccination.

Sønderskov K.M., Vistisen H.T., Dinesen P.T., Østergaard S.D. A positive update on COVID-19 booster vaccine willingness among Danes. Dan. Med. J. 2022;69:A01220047. PubMed

Sallam M., Dababseh D., Eid H., Al-Mahzoum K., Al-Haidar A., Taim D., Yaseen A., Ababneh N.A., Bakri F.G., Mahafzah A. High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries. Vaccines. 2021;9:42. doi: 10.3390/vaccines9010042. PubMed DOI PMC

Wang X., Liu L., Pei M., Li X., Li N. Willingness of the General Public to Receive A COVID-19 Vaccine Booster—China, April–May 2021. China CDC Wkly. 2022;4:66–70. doi: 10.46234/ccdcw2022.013. PubMed DOI PMC

Hu T., Li L., Lin C., Yang Z., Chow C., Lu Z., You C. An Analysis of the Willingness to the COVID-19 Vaccine Booster Shots among Urban Employees: Evidence from a Megacity H in Eastern China. Int. J. Environ. Res. Public Health. 2022;19:2300. doi: 10.3390/ijerph19042300. PubMed DOI PMC

Al Janabi T., Pino M. Predictors for Actual COVID-19 Vaccine Uptake and Intended Booster Dosage among Medical Students of an Osteopathic Medical School in New York. Epidemiologia. 2021;2:553–563.:38. doi: 10.3390/epidemiologia2040038. PubMed DOI PMC

Monkeypox Knowledge and Vaccine Hesitancy of Czech Healthcare Workers: A Health Belief Model (HBM)-Based Study

COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study